Rare Diseases
Article
NORD Call for Abstracts Reopened
Article
NORD Submits Comments to the Centers for Medicare and Medicaid Services
News
NORD Advocates for Iowa Co-pay Choice Bill
Article
Letter to Congress: NORD and Others Oppose “Right to Try”
Article
Rare Disease Day Events Planned for Campuses, Hospitals, and State Legislatures
Article
NORD to Moderate Panel at NIH Rare Disease Day Event
From the Journals
Mogamulizumab active in HTLV-1–associated myelopathy
The phase 1-2a study shows potential for mogamulizumab in the treatment of HAM-TSP.